|

68GA-DOTA-dPNE Clinical Trials

2 actively recruiting trials

Pipeline

Early 1: 1

Top Sponsors

  • Peking Union Medical College Hospital2

Indications

  • Cancer2
  • Tumor Immunity1
  • Breast Cancer1

Other2 trials

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer
Early 1
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.